Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7

Microbiology

Volumn 158, Issue 4, 2012, Pages 1071-1083

  Morita, Yuji ^a   Tomida, Junko ^a   Kawamura, Yoshiaki ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CARBENICILLIN; CEFEPIME; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; HABEKACIN; OUTER MEMBRANE PROTEIN; PROTEIN OPRA; PROTEIN OPRM; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; MEXAB GENE; MEXY GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPRA GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA;

AMINO ACID SEQUENCE; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CLONING, MOLECULAR; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE KNOCKOUT TECHNIQUES; GENETIC COMPLEMENTATION TEST; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS, DNA;

PSEUDOMONAS AERUGINOSA;

EID: 84859141794     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.054320-0     Document Type: Article

References (77)

1. Aires, J. R., Köhler, T., Nikaido, H. & Plésiat, P. (1999). Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 43, 2624-2628.
2. Alguel, Y., Lu, D., Quade, N., Sauter, S. & Zhang, X. (2010). Crystal structure of MexZ, a key repressor responsible for antibiotic resistance in Pseudomonas aeruginosa. J Struct Biol 172, 305-310.
3. Armstrong, E. S. & Miller, G. H. (2010). Combating evolution with intelligent design: the neoglycoside ACHN-490. Curr Opin Microbiol 13, 565-573.
4. Baum, E. Z., Crespo-Carbone, S. M., Morrow, B. J., Davies, T. A., Foleno, B. D., He, W., Queenan, A. M. & Bush, K. (2009). Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa. Antimicrob Agents Chemother 53, 2785-2790.
5. Becher, A. & Schweizer, H. P. (2000). Integration-proficient Pseudomonas aeruginosa vectors for isolation of single-copy chromosomal lacZ and lux gene fusions. Biotechniques 29, 948-950, 952.
6. Bert, F., Lambert-Zechovsky, N. & Seymour, A. C. (1996). Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards. J Antimicrob Chemother 37, 809-813.
7. Casin, I., Hanau-Berçot, B., Podglajen, I., Vahaboglu, H. & Collatz, E. (2003). Salmonella enterica serovar Typhimurium bla(PER-1)-carrying plasmid pSTI1 encodes an extended-spectrum aminoglycoside 69-N-acetyltransferase of type Ib. Antimicrob Agents Chemother 47, 697-703.
8. Caughlan, R. E., Sriram, S., Daigle, D. M., Woods, A. L., Buco, J., Peterson, R. L., Dzink-Fox, J., Walker, S. & Dean, C. R. (2009). Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression. Antimicrob Agents Chemother 53, 5015-5021.
9. +-coupled multidrug efflux pumps from Vibrio parahaemolyticus. J Bacteriol 184, 572-576.
10. de Bentzmann, S. & Plésiat, P. (2011). The Pseudomonas aeruginosa opportunistic pathogen and human infections. Environ Microbiol 13, 1655-1665.
11. Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P. E. & Bradford, P. A. (2003). Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother 47, 972-978.
12. Doi, Y. & Arakawa, Y. (2007). 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45, 88-94.
13. El'Garch, F., Jeannot, K., Hocquet, D., Llanes-Barakat, C. & Plésiat, P. (2007). Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 51, 1016-1021.
14. Fraud, S. & Poole, K. (2011). Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa. Antimicrob Agents Chemother 55, 1068-1074.
15. Giamarellos-Bourboulis, E. J., Papadimitriou, E., Galanakis, N., Antonopoulou, A., Tsaganos, T., Kanellakopoulou, K. & Giamarellou, H. (2006). Multidrug resistance to antimicrobials as a predominant factor influencing patient survival. Int J Antimicrob Agents 27, 476-481.
16. Hancock, R. E. (1998). Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria. Clin Infect Dis 27 (Suppl. 1), S93-S99.
17. Henrichfreise, B., Wiegand, I., Pfister, W. & Wiedemann, B. (2007). Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother 51, 4062-4070.
18. Hinz, A., Lee, S., Jacoby, K. & Manoil, C. (2011). Membrane proteases and aminoglycoside antibiotic resistance. J Bacteriol 193, 4790-4797.
19. Hirakawa, H., Nishino, K., Hirata, T. & Yamaguchi, A. (2003). Comprehensive studies of drug resistance mediated by overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J Bacteriol 185, 1851-1856.
20. Hoang, T. T., Karkhoff-Schweizer, R. R., Kutchma, A. J. & Schweizer, H. P. (1998). A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212, 77-86.
21. Hocquet, D., Nordmann, P., El Garch, F., Cabanne, L. & Plésiat, P. (2006). Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 50, 1347-1351.
22. Hocquet, D., Berthelot, P., Roussel-Delvallez, M., Favre, R., Jeannot, K., Bajolet, O., Marty, N., Grattard, F., Mariani-Kurkdjian, P. & other authors (2007). Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob Agents Chemother 51, 3531-3536.
23. Hocquet, D., Muller, A., Blanc, K., Plésiat, P., Talon, D., Monnet, D. L. & Bertrand, X. (2008). Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 52, 1173-1175.
24. Iida, T., Kaido, T., Yagi, S., Yoshizawa, A., Hata, K., Mizumoto, M., Mori, A., Ogura, Y., Oike, F. & Uemoto, S. (2010). Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl 16, 1379-1385.
25. Islam, S., Jalal, S. & Wretlind, B. (2004). Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 10, 877-883.
26. Jorgensen, J. H. & Turnidge, J. D. (2007). Susceptibility test methods: dilution and disk diffusion methods. In Manual of Clinical Microbiology, 9th edn, vol. 1, pp. 1152-1172. Edited by P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry & M. A. Pfaller. Washington, DC: American Society for Microbiology.
27. Kallen, A. J., Hidron, A. I., Patel, J. & Srinivasan, A. (2010). Multidrug resistance among gram-negative pathogens that caused healthcareassociated infections reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 31, 528-531.
28. Keen, E. F., III, Murray, C. K., Robinson, B. J., Hospenthal, D. R., Co, E. M. & Aldous, W. K. (2010). Changes in the incidences of multidrugresistant and extensively drug-resistant organisms isolated in a military medical center. Infect Control Hosp Epidemiol 31, 728-732.
29. Kiewitz, C. & Tümmler, B. (2000). Sequence diversity of Pseudomonas aeruginosa: impact on population structure and genome evolution. J Bacteriol 182, 3125-3135.
30. Kindrachuk, K. N., Fernandez, L., Bains, M. & Hancock, R. E. (2011). Involvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock response to tobramycin in Pseudomonas aeruginosa. Antimicrob Agents Chemother 55, 1874-1882.
31. King, J. D., Mulrooney, E. F., Vinogradov, E., Kneidinger, B., Mead, K. & Lam, J. S. (2008). lfnA from Pseudomonas aeruginosa O12 and wbuX from Escherichia coli O145 encode membrane-associated proteins and are required for expression of 2,6-dideoxy-2-acetamidino-L-galactose in lipopolysaccharide O antigen. J Bacteriol 190, 1671-1679.
32. Kirikae, T., Mizuguchi, Y. & Arakawa, Y. (2008). Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan. J Antimicrob Chemother 61, 612-615.
33. Kitao, T., Miyoshi-Akiyama, T. & Kirikae, T. (2009). AAC(69)-Iaf, a novel aminoglycoside 69-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 53, 2327-2334.
34. Lambert, T., Ploy, M. C. & Courvalin, P. (1994). A spontaneous point mutation in the aac(69)-Ib9 gene results in altered substrate specificity of aminoglycoside 69-N-acetyltransferase of a Pseudomonas fluorescens strain. FEMS Microbiol Lett 115, 297-304.
35. Lambert, M. L., Suetens, C., Savey, A., Palomar, M., Hiesmayr, M., Morales, I., Agodi, A., Frank, U., Mertens, K. & Schumacher, M. (2011). Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensivecare units: a cohort study. Lancet Infect Dis 11, 30-38.
36. Lee, S., Hinz, A., Bauerie, E., Angermeyer, A., Juhaszova, K., Kaneko, Y., Singh, P. K. & Manoll, C. (2009). Targeting a bacterial stress response to enhance antibiotic action. Proc Natl Acad Sci U S A 106, 14570-14575.
37. Legakis, N. J., Aliferopoulou, M., Papavassiliou, J. & Papapetropoulou, M. (1982). Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility. J Clin Microbiol 16, 458-463.
38. Li, L., He, Z., Pandey, G. K., Tsuchiya, T. & Luan, S. (2002). Functional cloning and characterization of a plant efflux carrier for multidrug and heavy metal detoxification. J Biol Chem 277, 5360-5368.
39. Link, A. J., Phillips, D. & Church, G. M. (1997). Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: application to open reading frame characterization. J Bacteriol 179, 6228-6237.
40. Lister, P. D., Wolter, D. J. & Hanson, N. D. (2009). Antibacterialresistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22, 582-610.
41. Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C. & Plésiat, P. (2004). Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob Agents Chemother 48, 1797-1802.
42. Mahar, P., Padiglione, A. A., Cleland, H., Paul, E., Hinrichs, M. & Wasiak, J. (2010). Pseudomonas aeruginosa bacteraemia in burns patients: risk factors and outcomes. Burns 36, 1228-1233.
43. Mao, W., Warren, M. S., Lee, A., Mistry, A. & Lomovskaya, O. (2001). MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45, 2001-2007.
44. Martin, N. L. & Beveridge, T. J. (1986). Gentamicin interaction with Pseudomonas aeruginosa cell envelope. Antimicrob Agents Chemother 29, 1079-1087.
45. Masaoka, Y., Ueno, Y., Morita, Y., Kuroda, T., Mizushima, T. & Tsuchiya, T. (2000). A two-component multidrug efflux pump, EbrAB, in Bacillus subtilis. J Bacteriol 182, 2307-2310.
46. Mauldin, P. D., Salgado, C. D., Hansen, I. S., Durup, D. T. & Bosso, J. A. (2010). Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob Agents Chemother 54, 109-115.
47. Mima, T. & Schweizer, H. P. (2010). The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. Antimicrob Agents Chemother 54, 3113-3120.
48. Mine, T., Morita, Y., Kataoka, A., Mizushima, T. & Tsuchiya, T. (1999). Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob Agents Chemother 43, 415-417.
49. Moore, R. A., DeShazer, D., Reckseidler, S., Weissman, A. & Woods, D. E. (1999). Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother 43, 465-470.
50. Morita, Y., Kodama, K., Shiota, S., Mine, T., Kataoka, A., Mizushima, T. & Tsuchiya, T. (1998). NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob Agents Chemother 42, 1778-1782.
51. Morita, Y., Kimura, N., Mima, T., Mizushima, T. & Tsuchiya, T. (2001). Roles of MexXY-and MexAB-multidrug efflux pumps in intrinsic multidrug resistance of Pseudomonas aeruginosa PAO1. J Gen Appl Microbiol 47, 27-32.
52. Morita, Y., Sobel, M. L. & Poole, K. (2006). Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene product. J Bacteriol 188, 1847-1855.
53. Morita, Y., Narita, S., Tomida, J., Tokuda, H. & Kawamura, Y. (2010). Application of an inducible system to engineer unmarked conditional mutants of essential genes of Pseudomonas aeruginosa. J Microbiol Methods 82, 205-213.
54. Mugnier, P., Casin, I., Bouthors, A. T. & Collatz, E. (1998). Novel OXA-10-derived extended-spectrum b-lactamases selected in vivo or in vitro. Antimicrob Agents Chemother 42, 3113-3116.
55. Muller, C., Plésiat, P. & Jeannot, K. (2011). A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and b-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother 55, 1211-1221.
56. Piddock, L. J. (2006). Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19, 382-402.
57. Pirnay, J. P., Bilocq, F., Pot, B., Cornelis, P., Zizi, M., Van Eldere, J., Deschaght, P., Vaneechoutte, M., Jennes, S. & other authors (2009). Pseudomonas aeruginosa population structure revisited. PLoS ONE 4, e7740.
58. Pitt, T. L., Livermore, D. M., Miller, G., Vatopoulos, A. & Legakis, N. J. (1990). Resistance mechanisms of multiresistant serotype O12 Pseudomonas aeruginosa isolated in Europe. J Antimicrob Chemother 26, 319-328.
59. Poole, K. (2002). Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. Curr Pharm Biotechnol 3, 77-98.
60. Poole, K. (2005). Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49, 479-487.
61. Poole, K. (2011). Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2, 65.
62. Poole, K., Krebes, K., McNally, C. & Neshat, S. (1993). Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 175, 7363-7372.
63. Rather, P. N., Munayyer, H., Mann, P. A., Hare, R. S., Miller, G. H. & Shaw, K. J. (1992). Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 69-N-acetyltransferase Ib and IIa proteins. J Bacteriol 174, 3196-3203.
64. Roy, P. H., Tetu, S. G., Larouche, A., Elbourne, L., Tremblay, S., Ren, Q., Dodson, R., Harkins, D., Shay, R. & other authors (2010). Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7. PLoS ONE 5, e8842.
65. Samuelsen, O., Toleman, M. A., Sundsfjord, A., Rydberg, J., Leegaard, T. M., Walder, M., Lia, A., Ranheim, T. E., Rajendra, Y. & other authors (2010). Molecular epidemiology of metallo-betalactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother 54, 346-352.
66. Schurek, K. N., Marr, A. K., Taylor, P. K., Wiegand, I., Semenec, L., Khaira, B. K. & Hancock, R. E. (2008). Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 52, 4213-4219.
67. Sekiguchi, J., Asagi, T., Miyoshi-Akiyama, T., Fujino, T., Kobayashi, I., Morita, K., Kikuchi, Y., Kuratsuji, T. & Kirikae, T. (2005). Multidrugresistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(69)-Iae gene cassette encoding a novel aminoglycoside acetyltransferase. Antimicrob Agents Chemother 49, 3734-3742.
68. Sekiguchi, J., Asagi, T., Miyoshi-Akiyama, T., Kasai, A., Mizuguchi, Y., Araake, M., Fujino, T., Kikuchi, H., Sasaki, S. & other authors (2007). Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol 45, 979-989.
69. Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D'Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P. & other authors (2006). Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103, 8487-8492.
70. Sobel, M. L., McKay, G. A. & Poole, K. (2003). Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 47, 3202-3207.
71. Struble, J. M. & Gill, R. T. (2009). Genome-scale identification method to find cryptic aminoglycoside resistance genes in Pseudomonas aeruginosa. PLoS One 4, e6576.
72. Swick, M. C., Morgan-Linnell, S. K., Carlson, K. M. & Zechiedrich, L. (2011). Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance. Antimicrob Agents Chemother 55, 921-924.
73. Tikhonova, E. B., Yamada, Y. & Zgurskaya, H. I. (2011). Sequential mechanism of assembly of multidrug efflux pump AcrAB-TolC. Chem Biol 18, 454-463.
74. Vettoretti, L., Plésiat, P., Muller, C., El Garch, F., Phan, G., Attrée, I., Ducruix, A. & Llanes, C. (2009). Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 53, 1987-1997.
75. Vogne, C., Aires, J. R., Bailly, C., Hocquet, D. & Plésiat, P. (2004). Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 48, 1676-1680.
76. Woodford, N., Turton, J. F. & Livermore, D. M. (2011). Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35, 736-755.
77. Yokoyama, K., Doi, Y., Yamane, K., Kurokawa, H., Shibata, N., Shibayama, K., Yagi, T., Kato, H. & Arakawa, Y. (2003). Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 362, 1888-1893.